ntr121-C_202401645EN.000101-E0121
(121) In particular alongside products with the same intended use(s). Relevant examples of such assessments can be found in the pharmaceutical industry. See, for example, case M.7275 Novartis/GlaxoSmithKline Oncology Business, paragraphs 23-31, where the Commission assessed the B-Raf inhibitors and MEK inhibitors under development by the parties as part of the market for targeted therapies for the treatment of advanced melanoma, in which existing products were already marketed. Other examples concern high technology products, such as heavy-duty gas turbines assessed in case M.7278 General Electric/Alstom (Thermal Power Renewable Power & Grid Business), paragraphs 985-991, where the Commission assessed Alstom’s pipeline heavy-duty gas turbine as part of the existing product market for heavy-duty gas turbines.
Source: EUR-Lex (Cellar) · retrieved 2026-09-25 · Text as adopted (Official Journal); later amendments are not incorporated in this text.